[Update on current care guidelines: benign prostatic hyperplasia].
Most benign prostatic hyperplasia (BPH) patients can be diagnosed and treated in primary care. Evaluation requires a medical history and a symptom score (DAN-PSS or IPSS) and a careful physical examination including a digital rectal examination. Careful follow-up and medical therapy are the usual first-line management options in uncomplicated BPH. Combination therapy with both alpha-blocker and 5alpha-reductase inhibitor is the most effective medical treatment modality. Transurethral resection (TURP) is a safe and effective way of treating BPH. The green laser is the most promising new endoscopic treatment modality.
Teuvo
T
Tammela
Martti
M
Nurmi
Anssi
A
Pétas
Raija
R
Sipilä
Kimmo
K
Taari
D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D004724:Endoscopy; D006801:Humans; D053685:Laser Therapy; D008297:Male; D008487:Medical History Taking; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000628:therapy*; D020728:Transurethral Resection of Prostate
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists